Wesana Revenue and Competitors

Location

$16.8M

Total Funding

Medical

Industry

Estimated Revenue & Valuation

  • Wesana's estimated annual revenue is currently $3.5M per year.(i)
  • Wesana's estimated revenue per employee is $388,889
  • Wesana's total funding is $16.8M.

Employee Data

  • Wesana has 9 Employees.(i)
  • Wesana grew their employee count by -44% last year.

Wesana's People

NameTitleEmail/Phone
1
Co-Founder and CEOReveal Email/Phone
2
Psychiatrist/Medical DirectorReveal Email/Phone
3
Senior Corporate CounselReveal Email/Phone
4
Marketing CoordinatorReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$7.5M39-22%N/AN/A
#2
N/A16167%N/AN/A
#3
N/A22645%N/AN/A
#4
N/A7129%N/AN/A
#5
N/A5531%N/AN/A
#6
N/A16220%N/AN/A
#7
N/A7423%N/AN/A
#8
N/A8-27%N/AN/A
#9
$3.5M300%N/AN/A
#10
N/A525%N/AN/A
Add Company

What Is Wesana?

Founder Daniel Carcillo played 9 years in the NHL, won 2 Stanley Cups and was forced to retire at the age of 30 after 7 concussions due to Post Concussion Syndrome. Daniel spent the past 5 years trying different clinical concussion treatments, spent hundreds of thousands of dollars and was no closer to improving his brain health and quality of life. Hopeless, Daniel turned to mushrooms containing psilocybin, medicinal mushrooms like lion's mane, reishi and cordyceps, as well as CBD to regain his brain health. 6 months into his journey, he received news that his brain scans had no abnormalities and his bloodwork was all clear, confirming how he now felt.

keywords:N/A

$16.8M

Total Funding

9

Number of Employees

$3.5M

Revenue (est)

-44%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Wesana News

2022-04-17 - EXCLUSIVE: Daniel Carcillo Explains How Wesana Health Is Using Psychedelics To Treat Traumatic Brain Inju

Wesana is exploring the combination of psilocybin and cannabidiol (CBD), to increase neurogenesis and neuroplasticity and reduce brain damage...

2022-04-13 - Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat ...

(“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow...

2022-03-22 - Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF),...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.7M9N/AN/A
#2
$0.7M9N/AN/A
#3
$0.7M9N/AN/A
#4
$0.7M9N/AN/A
#5
$0.7M9N/AN/A